Showing 1 - 10 of 16
Which costs and benefits to consider in economic evaluations of healthcare interventions remains an area of much controversy. Unrelated medical costs in life-years gained is an important cost category that is normally ignored in economic evaluations, irrespective of the perspective chosen for...
Persistent link: https://www.econbiz.de/10005590343
Background: Obesity is a major contributor to the overall burden of disease (also reducing life expectancy) and associated with high medical costs due to obesity-related diseases. However, obesity prevention, while reducing obesity-related morbidity and mortality, may not result in overall...
Persistent link: https://www.econbiz.de/10008496160
Persistent link: https://www.econbiz.de/10005508925
Persistent link: https://www.econbiz.de/10005509005
Persistent link: https://www.econbiz.de/10005509078
Persistent link: https://www.econbiz.de/10005520845
Persistent link: https://www.econbiz.de/10010826458
An important subject of debate in cost-utility analysis of health care programmes is whether to include costs of unrelated medical care in life years gained. The inclusion of such costs is likely to be of consequence in the case of primary prevention. This paper presents different strategies...
Persistent link: https://www.econbiz.de/10005689996
The TTO-method is often used to value health states, but it is susceptible to several biases and methodological difficulties. One of these is a violation of procedural invariance, which means that the way a TTO-question is framed, i.e. either by fixing the period in imperfect health or that in...
Persistent link: https://www.econbiz.de/10005694104
The objective of the present study was to evaluate whether people include the effects of ill-health on income and leisure in quality of life valuation when the measure is silent on both. A convenience sample of 20 health professionals had to rate a health status on a visual analogue scale (VAS)...
Persistent link: https://www.econbiz.de/10005792767